Document is current
Any future updates will be listed below
-
Authors
Lynch, Miranda L. https://orcid.org/0000-0001-8604-4431
DeGruttola, Victor
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (NIAID R37 51164)
National Institutes of Health (R24 AI106039, R01 AI135992)
National Institutes of Health (P30 AI036214, P01 AI131385)
- License Information
-
More Information
Article History
Received: 25 September 2021
Accepted: 31 March 2022
First Online: 4 May 2022
Declarations
:
: None to declare.
: Not applicable, as this study was a secondary analysis of existing data. All data used in the application section were from a previously reported trial study. We mention that the original study was subject to study protocol IRB approval and informed consent acquisition in accordance with guidelines for human experimentation as specified by the US Department of Health and Human Services, the original study authors’ institutions, or both, as reported in [].
: This work was supported by the National Institutes of Health [grant numbers NIAID R37 51164, NIH R24 AI106039, NIH P30 AI036214, NIH R56 AI158293, NIH P01 AI131385 and NIH R01 AI135992 for VDG]. Funding sources had no role in the design of the study or the collected data, or in the analyses and interpretation of the results, or manuscript preparation.
: Not applicable
